Melanie M. van der Klauw

ORCID: 0000-0001-7178-009X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes and associated disorders
  • Genetic Associations and Epidemiology
  • Advanced Glycation End Products research
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diet and metabolism studies
  • Diabetes Management and Research
  • Pituitary Gland Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Hormonal Regulation and Hypertension
  • Diabetes Treatment and Management
  • Thyroid Disorders and Treatments
  • Diet, Metabolism, and Disease
  • Adrenal Hormones and Disorders
  • Acute Myeloid Leukemia Research
  • Drug-Induced Adverse Reactions
  • Alcohol Consumption and Health Effects
  • Stress Responses and Cortisol
  • Thyroid Cancer Diagnosis and Treatment
  • Pharmaceutical studies and practices
  • Skin Protection and Aging
  • Hemoglobinopathies and Related Disorders
  • Genetic Mapping and Diversity in Plants and Animals
  • Blood disorders and treatments
  • Cardiovascular Disease and Adiposity
  • Respiratory and Cough-Related Research

University Medical Center Groningen
2016-2025

University of Groningen
2016-2025

University of Duisburg-Essen
2016

Karolinska Institutet
2016

Maastricht University Medical Centre
2004-2005

Maastricht University
2004

Dutch Health Care Inspectorate
1996-1998

Albert Schweitzer Ziekenhuis
1998

Erasmus University Rotterdam
1990-1996

Medisch Centrum Leeuwarden
1994

Not all obese subjects have an adverse metabolic profile predisposing them to developing type 2 diabetes or cardiovascular disease. The BioSHaRE-EU Healthy Obese Project aims gain insights into the consequences of (healthy) obesity using data on risk factors and phenotypes across several large-scale cohort studies. Aim this study was describe prevalence obesity, syndrome (MetS) metabolically healthy (MHO) in ten participating studies.Ten different cohorts seven countries were combined,...

10.1186/1472-6823-14-9 article EN cc-by BMC Endocrine Disorders 2014-02-01
John C. Chambers Wei Zhang Joban Sehmi Man Li Mark N. Wass and 95 more Pim van der Harst Hilma Hólm Serena Sanna Maryam Kavousi Sebastian E. Baumeister Lachlan Coin Guohong Deng Christian Gieger Nancy L. Heard‐Costa Jouke‐Jan Hottenga Brigitte Kühnel Vinod Kumar Vasiliki Lagou Liming Liang Jian'an Luan Pedro Marques‐Vidal Irene Mateo Leach Paul F. O’Reilly John F. Peden Nilüfer Rahmioğlu Pasi Soininen Elizabeth K. Speliotes Xin Yuan Guðmar Þorleifsson Behrooz Z. Alizadeh Larry D. Atwood Ingrid B. Borecki Matthew A. Brown Pimphen Charoen Francesco Cucca Debashish Das Eco J. C. de Geus Anna Dixon Angela Döring Georg Ehret Guðmundur I. Eyjólfsson Martin Farrall Nita G. Forouhi Nele Friedrich Wolfram Goessling Daníel F. Guðbjartsson Tamara B. Harris Anna‐Liisa Hartikainen Simon Heath Gideon M. Hirschfield Albert Hofman Georg Homuth Elina Hyppönen Harry L.A. Janssen Toby Johnson Antti J. Kangas Ido P. Kema Jens‐Peter Kühn Sandra Lai Mark Lathrop Markus M. Lerch Yun Li T. Jake Liang Jing‐Ping Lin Ruth J. F. Loos Nicholas G. Martin Miriam F. Moffatt Grant W. Montgomery Patricia B. Munroe Yan V. Sun Yusuke Nakamura Christopher J. O’Donnell Isleifur Olafsson Brenda W.J.H. Penninx Anneli Pouta Bram P. Prins Inga Prokopenko Ralf Puls Aimo Ruokonen Markku J. Savolainen David Schlessinger Jeoffrey Schouten Udo Seedorf Srijita Sen‐Chowdhry Katherine A. Siminovitch Johannes H. Smit Timothy D Spector Wenting Tan Tanya M. Teslovich Taru Tukiainen André G. Uitterlinden Melanie M. van der Klauw Ramachandran S. Vasan Chris Wallace Henri Wallaschofski H‐Erich Wichmann Gonneke Willemsen Peter Würtz Chun Xu Laura M. Yerges‐Armstrong

10.1038/ng.970 article EN Nature Genetics 2011-10-16

Anemia is highly prevalent, especially in older individuals. In selected populations, anemia has been reported to be associated with impaired survival and health-related quality of life. However, data on this impact the general population are rare. Furthermore, discussions optimal definition have not conclusive. We investigated these issues using data, scores from a life questionnaire (RAND-36), hemoglobin concentration 138670 subjects, aged 18-93 years, participating Lifelines cohort. was...

10.3324/haematol.2018.195552 article EN cc-by-nc Haematologica 2018-10-11
Jeannette Simino Gang Shi Joshua C. Bis Daniel I. Chasman Georg Ehret and 95 more Xiangjun Gu Xiuqing Guo Shih-Jen Hwang Eric J.G. Sijbrands Albert V. Smith Germaine C. Verwoert Jennifer L. Bragg‐Gresham Gemma Cadby Peng Chen Ching‐Yu Cheng Tanguy Corre Rudolf A. de Boer Anuj Goel Toby Johnson Chiea Chuen Khor Carla Lluís-Ganella Jian’an Luan Leo‐Pekka Lyytikäinen Ilja M. Nolte Xueling Sim Siim Sõber Peter J. van der Most Niek Verweij Jing Hua Zhao Najaf Amin Eric Boerwinkle Claude Bouchard Abbas Dehghan Guðný Eiríksdóttir Roberto Elosúa Oscar H. Franco Christian Gieger Tamara B. Harris Serge Herçberg Albert Hofman Anthony James Andrew D. Johnson Mika Kähönen Kay‐Tee Khaw Zoltán Kutalik Martin G. Larson Lenore J. Launer Li Guo Jianjun Liu Kiang Liu Alanna C. Morrison Gerjan Navis Rick Twee‐Hee Ong George J. Papanicolau Brenda W.J.H. Penninx Bruce M. Psaty Leslie J. Raffel Olli T. Raitakari Kenneth Rice Fernando Rivadeneira Lynda M. Rose Serena Sanna Robert A. Scott David S. Siscovick Ronald P. Stolk André G. Uitterlinden Dhananjay Vaidya Melanie M. van der Klauw Ramachandran S. Vasan Eranga N. Vithana Uwe Völker Henry Völzke Hugh Watkins Terri L. Young Tin Aung Murielle Bochud Martin Farrall Catharina A. Hartman Maris Laan Edward G. Lakatta Terho Lehtimäki Ruth J. F. Loos Gavin Lucas Pierre Meneton Lyle J. Palmer Rainer Rettig Harold Snieder E. Shyong Tai Yik-Ying Teo Pim van der Harst Nicholas J. Wareham Cisca Wijmenga Tien Yin Wong Myriam Fornage Vilmundur Guðnason Daniel Levy Walter Palmas Paul M. Ridker Jerome I. Rotter Cornelia M. van Duijn

10.1016/j.ajhg.2014.05.010 article EN publisher-specific-oa The American Journal of Human Genetics 2014-06-19

Earlier studies have shown that skin autofluorescence measured with an AGE reader estimates the accumulation of AGEs in skin, which increases ageing and is associated metabolic syndrome type 2 diabetes. In present study, we examined whether measurement can predict 4 year risk incident diabetes, cardiovascular disease (CVD) mortality general population. For this prospective analysis, included 72,880 participants Dutch Lifelines Cohort Study, who underwent baseline investigations between 2007...

10.1007/s00125-018-4769-x article EN cc-by Diabetologia 2018-11-17

Introduction: The presence of the Thr92Ala polymorphism deiodinase-2 (D2) has been thought to have several effects. It may influence its enzymatic function, is associated with increased expression genes involved in oxidative stress brain tissue, and predict favorable response combination levothyroxine (LT4) plus triiodothyronine (T3) therapy. was hypothesized that homozygous carriers D2-92Ala allele different thyroid hormone parameters, reduced health-related quality life (HRQoL) cognitive...

10.1089/thy.2016.0199 article EN Thyroid 2016-10-27

ABSTRACT Glycogen storage disease type Ia (GSDIa) is a rare, life‐threatening, inherited carbohydrate metabolism disorder caused by glucose‐6‐phosphatase (G6Pase) deficiency, which essential for glycogenolysis and gluconeogenesis. GSDIa management includes strict medically prescribed diet that typically daily uncooked cornstarch doses, including overnight, to maintain euglycemia. DTX401 an investigational adeno‐associated virus serotype 8 vector expressing the human G6PC1 gene encodes...

10.1002/jimd.70014 article EN cc-by Journal of Inherited Metabolic Disease 2025-03-01

Agranulocytosis is a life-threatening disorder, often caused by drugs. Incidences or risks of drug-induced agranulocytosis are not well known, since it rare.To determine the risk drug-associated as reason for admission to Dutch hospitals, we performed population-based case-cohort study. Hospital discharge data came from Centre Health Care Information, Utrecht, which contains on all general and university hospitals in Netherlands. The reference cohort consisted persons catchment area Pharmaco...

10.1001/archinte.159.4.369 article EN Archives of Internal Medicine 1999-02-22

Health-related quality of life (HR-QoL) may be compromised in obese individuals, depending on the presence other complications. The aim this study is to assess effect obesity-related conditions HR-QoL. These are i) grade obesity with and without type 2 diabetes (T2D), ii) metabolic syndrome (MetS), iii) level inflammation.From Dutch LifeLines Cohort Study we included 13,686 aged 18-80 years. HR-QoL was measured RAND 36-Item Health Survey which encompasses eight health domains. We calculated...

10.1371/journal.pone.0140599 article EN cc-by PLoS ONE 2015-10-16

Introduction The development of metabolic syndrome (MetS) is influenced by environmental factors such as smoking and alcohol consumption. We determined the combined effects on MetS its individual components. Methods 64,046 participants aged 18–80 years from LifeLines Cohort study were categorized into three body mass index (BMI) classes (BMI<25, normal weight; BMI 25–30, overweight; BMI≥30 kg/m2, obese). was defined according to revised criteria National Cholesterol Education Program's Adult...

10.1371/journal.pone.0096406 article EN cc-by PLoS ONE 2014-04-29

Abstract Background Skin autofluorescence ( SAF ) is a noninvasive marker of advanced glycation end products AGE s). In diabetes, higher levels have been positively associated with long‐term complications, cardiovascular morbidity and mortality. Because little known about the factors that influence in nondiabetic individuals, we assessed association clinical lifestyle parameters as well their interactions large‐scale, population performed same analysis type 2 diabetic subgroup. Methods...

10.1111/eci.12627 article EN cc-by-nc European Journal of Clinical Investigation 2016-03-22

Diversity in the reported prevalence of metabolically healthy obesity (MHO), suggests that modifiable factors may be at play. We evaluated differences dietary patterns and physical activity between MHO unhealthy (MUO). Cross-sectional data 9270 obese individuals (30–69 years) Lifelines Cohort Study was used. defined as no metabolic syndrome risk cardiovascular disease history. MUO ≥2 factors. Sex-specific associations (identified by principal component analysis) with were assessed...

10.1186/s12937-018-0319-0 article EN cc-by Nutrition Journal 2018-02-12

Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of (IAH), and increase the severe The aim this study was to assess prevalence determinants self-reported IAH in a Dutch nationwide cohort people insulin-treated diabetes. Research design methods Observational Diabetes Pearl, treated primary, secondary tertiary care centers. presence occurrence past year, defined as an event requiring external help recover, were...

10.1136/bmjdrc-2019-000935 article EN cc-by-nc BMJ Open Diabetes Research & Care 2020-02-01

1. In order to determine the risk of anaphylaxis as an adverse reaction drugs, a case‐cohort study was performed. Cases consisted all admissions in 1987 and 1988 Dutch hospitals with principal diagnosis, random sample related symptoms. Hospital discharge summaries were classified according probability by blinded Audit Committee. Of probable or possible anaphylaxis, causative agent assessed. The reference cohort persons catchment area pharmacies Netherlands, period between January 1, December...

10.1111/j.1365-2125.1993.tb04157.x article EN British Journal of Clinical Pharmacology 1993-04-01

Introduction To evaluate the prevalence of metabolic syndrome (MetS) and its individual components within sex-, body mass index (BMI)- age combined clusters. In addition, we used age-adjusted blood pressure thresholds to demonstrate effect on MetS elevated pressure. Subjects methods Cross-sectional data from 74,531 Western European participants, aged 18–79 years, were Dutch Lifelines Cohort Study. was defined according revised NCEP-ATPIII. Age-adjusted as recommended by eight reports Joint...

10.1530/ec-17-0011 article EN cc-by-nc-nd Endocrine Connections 2017-04-19

The metabolic syndrome (MetS) is a combination of unfavourable health factors which includes abdominal obesity, dyslipidaemia, elevated blood pressure and impaired fasting glucose. Earlier studies have reported relationship between thyroid function some MetS components or suggested that serum free thyroxine (FT4) triiodothyronine (FT3) levels within the normal range were independently associated with insulin resistance. We assessed how relates to prevalence in large population-based study....

10.1186/s12902-017-0215-1 article EN cc-by BMC Endocrine Disorders 2017-10-16

The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is complications in subjects diabetes. aim the present study was to examine association between SAF presence MetS as well its individual components general population. For this cross-sectional analysis, we included 78,671 non-diabetic 18...

10.1186/s13098-017-0241-1 article EN cc-by Diabetology & Metabolic Syndrome 2017-05-30

Abstract Erythrocytosis is a common reason for referral to hematology services and usually secondary in origin. The aim of this study was assess clinical characteristics clonal hematopoiesis (CH) individuals with erythrocytosis the population-based Lifelines cohort (n = 147 167). defined using strict (World Health Organization [WHO] 2008/British Committee Standards Hematology) wide (WHO 2016) criteria. Individuals (strict criteria) concurrent leukocytosis and/or thrombocytosis were 1:2...

10.1182/bloodadvances.2020003323 article EN cc-by-nc-nd Blood Advances 2020-12-21
Coming Soon ...